109047 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof General methods applicable to biologically active non-coding nucleic acids
iRNA agents with biocleavable tethers
#3902Method for inhibiting the activity of mir-155
#3903METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#3904Double stranded nucleic acid targeting low copy promoter-specific RNA
#3905LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
#3906DELIVERY METHOD
#3907siRNA targeting cyclin dependent kinase 11 (CDK11)
#3908siRNA targeting KRAS
#3909Methods of determining potency of chemically-synthesized oligonucleotides
#3910Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#3911Treatment of cancer using TLR3 agonists
#3912INERT DNA SEQUENCES FOR EFFICIENT VIRAL PACKAGING AND METHODS OF USE
#3913Dinucleotide MRNA cap analogs
#3914USE OF SHORT OLIGONUCLEOTIDES FOR REAGENT REDUNDANCY EXPERIMENTS IN RNA FUNCTIONAL ANALYSIS
#3915Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
#3916Controlled Release Devices and Methods for Delivery of Nucleic Acids
#3917Uniform field magnetization and targeting of therapeutic formulations
#3918BIOASSAY FOR GENE SILENCING CONSTRUCTS
#3919Micro-RNA scaffolds, non-naturally occurring micro-RNAs, and methods for optimizing non-naturally occurring micro-RNAs
#3920Integrated—ligand-responsive microRNAs
#3921Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
#3922Dendritic cell vaccine compositions and uses of same
#3923METHODS FOR ASSESSING THE DELIVERY OF EXOGENOUS AGENTS
#3924Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#3925MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES
#3926siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
#3927Biologic Modulations with Nanoparticles
#3928Therapeutic compositions
#3929METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#3930RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
#3931SiRNA targeting glucagon receptor (GCGR)
#3932BACTERIAL MEDIATED TNF ALPHA GENE SILENCING
#3933siRNA target hypoxia-inducible factor 1
#3934siRNA targeting gremlin
#3935Vivo production of small interfering RNAs that mediate gene silencing
#3936Hindered ester-based biodegradable linkers for oligonucleotide delivery
#3937System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron
#3938Antibacterial antisense oligonucleotide and method
#3939ANTISENSE ANTIBACTERIAL METHOD AND COMPOUND
#3940In vivo production of small interfering RNAS that mediate gene silencing
#3941TUNABLE AFFINITY LIGANDS FOR THE SEPARATION AND DETECTION OF TARGET SUBSTANCES
#3942RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3943Compositions comprising MIR34 therapeutic agents for treating cancer
#3944Method for controlling the amount of gene product, and agent for controlling the amount of gene product
#3945Genetic control of mammalian cells with synthetic RNA regulatory systems
#3946Categorization of Microbial Communities
#3947siRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
#3948High potency siRNAS for reducing the expression of target genes
#3949Methods to regulate miRNA processing by targeting Lin-28
#3950Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
#3951AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL
#3952Compositions and methods for modulation of SMN2 splicing
#3953Oligonucleotide analogues incorporating 5-aza-cytosine therein
#3954THERAPEUTIC DELIVERY OF INHIBITORY NUCLEIC ACID MOLECULES TO THE RESPIRATORY SYSTEM
#3955Short oligomer antagonist compounds for the modulation of target mRNA
#3956METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCV
#3957Nicked or gapped nucleic acid molecules and uses thereof
#3958Targeted delivery of siRNA
#3959INFLUENZA THERAPEUTIC
#3960TARGETS FOR TUMOR GROWTH INHIBITION
#3961Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
#3962Antisense compounds
#3963MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE
#3964Application of RNA Interference Targeting dhfr Gene, to Cell for Producing Secretory Protein
#3965Modulation of blood brain barrier protein expression
#3966Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level
#3967NANOPARTICLE COMPOSITIONS FOR CONTROLLED DELIVERY OF NUCLEIC ACIDS
#3968SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)
#39695'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
#3970DELIVERY OF NUCLEIC ACIDS USING CELL-PENETRATING PEPTIDES
#3971Method of producing recombinant biological products
#3972siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS
#3973P53 modulator and cancer target
#3974E. Coli Mediated Gene Silencing of Beta-Catenin
#3975Isolation of novel AAV'S and uses thereof
#3976CELL-BASED RNA INTERFERENCE AND RELATED METHODS AND COMPOSITIONS
#3977EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
#3978PRIMARY MICRO RNA EXPRESSION CASSETTE
#3979Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA
#3980Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#3981Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#3982Methods and compositions for enhancing the efficacy and specificity of RNA silencing
#3983Method of modulating the activity of a nucleic acid molecule
#3984METHODS AND COMPOSITIONS RELATED TO RIBOSWITCHES THAT CONTROL ALTERNATIVE SPLICING
#3985COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE
#3986Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
#3987Multifunctional nucleic acid nano-structures
#3988Modified iRNA agents
#3989GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF CANCERS
#3990AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME
#3991Tunable genetic switch for regulating gene expression
#3992Extended dicer substrate agents and methods for the specific inhibition of gene expression
#3993EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
#3994METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#3995COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS
#3996Rna constructs
#3997RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#3998siRNA compositions and methods for potently inhibiting viral infection
#3999Pharmaceutical composition
#4000Methods and compositions concerning siRNA's as mediators of RNA interference
#4001Method for treatment of Huntington's disease through intracranial delivery of sirna
#4002siRNA Kinase and Methods of Use
#4003Use of double stranded RNA hairpin duplexes in gene silencing
#4004siRNA targeting BCL2L1
#4005siRNA targeting nucleoporin 62kDa (Nup62)
#4006OLIGONUCLEOTIDE SYSTEMS FOR TARGETED INTRACELLULAR DELIVERY
#4007RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
#4008BLOCKING OF GENE EXPRESSION IN EUKARYOTIC CELLS
#4009siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
#4010Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell
#4011FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs
#4012RAS-MEDIATED EPIGENETIC SILENCING EFFECTORS AND USES THEREOF
#4013SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME
#4014DOUBLE-STRANDED OLIGONUCLEOTIDES
#4015Polyvalent RNA-nanoparticle compositions
#4016Dendrimer-like modular delivery vector
#4017Pure miRNA Sample Preparation Method
#4018Multiple exon skipping compositions for DMD
#4019Lipid formulations for nucleic acid delivery
#4020COMPOUNDS AND METHODS FOR PEPTIDE RIBONUCLEIC ACID CONDENSATE PARTICLES FOR RNA THERAPEUTICS
#4021Inhibition of autophagy genes in cancer chemotherapy
#4022METHODS AND COMPOSITIONS FOR MODULATING THE MIRNA PATHWAY
#4023Method of using gold nanorods-siRNA complexes
#4024Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle
#4025Compositions and methods for inhibiting expression of transthyretin
#4026siRNA targeting beta secretase (BACE)
#4027SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)
#4028METHOD OF TREATING AN INFLAMMATORY DISEASE BY DOUBLE STRANDED RIBONUCLEIC ACID
#4029siRNA targeting vascular endothelial growth factor (VEGF)
#4030siRNA targeting connective tissue growth factor (CTGF)
#4031SMALL INTERFERING RNA (SIRNA) TARGET SITE BLOCKING OLIGOS AND USES THEREOF
#4032Short hairpin RNAs for inhibition of gene expression
#4033Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
#4034Evolved orthogonal ribosomes
#4035NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF
#4036Photocleavable sense-antisense complex
#4037GENES INVOLVED IN MITOCHONDRIAL BIOGENESIS
#4038EARLY INTERVENTION OF VIRAL INFECTION WITH IMMUNE ACTIVATORS
#4039SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1)
#4040RNA interference tags
#4041Inhibitor Nucleic Acids
#4042METHOD AND KIT FOR EFFICIENT REPROGRAMMING OF SOMATIC CELLS
#4043Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference
#4044Modification of exosomal components for use as a vaccine
#4045Bacteria mediated gene silencing
#4046METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME
#4047METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#4048Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
#4049siRNA targeting spleen tyrosine kinase
#4050siRNA targeting superoxide dismutase 1 (SOD1)
#4051Isoform of bruton's tyrosine kinase (BTK) protein
#4052Olig1 mini-promoters
#4053COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS
#4054Sensizitation of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions
#4055siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
#4056METHODS AND COMPOSITIONS RELATING TO POLYPEPTIDES WITH RNASE III DOMAINS THAT MEDIATE RNA INTERFERENCE
#4057siRNA targeting amyloid beta (A4) precursor protein (APP)
#4058Chemically modified oligonucleotides
#4059METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4060siRNA targeting proto-oncogene MET
#4061Multi-microRNA methods and compositions
#4062Treatment of neurodegenerative disease through intracranial delivery of SIRNA
#4063SMALL INTERFERING RNA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING THE SAME
#4064Prompt nucleic acid delivery carrier composition
#4065siRNA targeting TIE-2
#4066Hydroxymethyl substituted RNA oligonucleotides and RNA complexes
#4067CYCLODEXTRIN CONJUGATES
#4068siRNA targeting coatomer protein complex, subunit beta 2 (CPOB2)
#4069INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS
#4070siRNA targeting tumor protein 53 (p53)
#4071Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers
#4072HYBRIDIZATION-STABILIZING CONSTRUCT
#4073Modified Oligonucleotides For The Treatment Of Hepatitis C Infection
#4074COMPOSITIONS COMPRISING A SIRNA AND LIPIDIC 4,5-DISUBSTITUTED 2-DEOXYSTREPTAMINE RING AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF
#4075RNAi inhibition of CTGF for treatment of ocular disorders
#4076Methods and compositions for regulating cell cycle progression
#4077METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#4078siRNA targeting survivin
#4079METHOD OF IDENTIFYING MICRO-RNA TARGETS
#4080System and methods for identifying miRNA targets and for altering miRNA and target expression
#4081RNAi expression constructs
#4082Retroviral vectors for delivery of interfering RNA
#4083High throughput assay for cancer cell growth inhibition
#4084Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell Transplantation
#4085siRNA targeting kinase insert domain receptor (KDR)
#4086Long interfering nucleic acid duplexes targeting multiple RNA targets
#4087SiRNA targeting ras-related nuclear protein RAN
#4088OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY
#40892′-hydroxyl group-modified ribonucleoside derivatives
#4090SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#4091Rna Nanoparticles and Nanotubes
#4092siRNA targeting histamine receptor H1
#4093NANOPARTICLES FOR NUCLEIC ACID DELIVERY
#4094RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES
#4095siRNA targeting hypoxia-inducible factor 1
#4096MicroRNA biomarkers for human breast and lung cancer
#4097Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery system
#4098Randomized dna libraries and double-stranded rna libraries, use and method of production thereof
#4099COMPOSITIONS AND METHODS FOR SPECIFICALLY SILENCING A TARGET NUCLEIC ACID
#4100Biologically active molecules, particularly based on PNA and siRNA, method for the cell-specific activation thereof, and application kit to be administered
#4101TARGETED DELIVERY TO LEUKOCYTES USING NON-PROTEIN CARRIERS
#4102METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4103METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4104METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4105METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4106METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4107siRNA targeting myeloid cell Leukemia sequence 1
#4108siRNA targeting polo-like Kinase-1 (PLK-1)
#4109METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4110Multivalent rna nanoparticles for delivery of active agents to a cell
#4111Methods and compositions for generating recombinant nucleic acid molecules
#4112Modulation of gene expression through endogenous small RNA targeting of gene promoters
#4113METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4114siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
#4115METHOD OF PREPARING siRNAs FOR SELECTIVE INHIBITION OF TARGET mRNA ISOTYPES
#4116METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4117METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4118METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#4119KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK
#4120Oligonucleotides comprising a non-phosphate backbone linkage
#4121Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#4122GENE SILENCING USING SENSE DNA AND ANTISENSE RNA HYBRID CONSTRUCTS COUPLED TO PEPTIDES FACILITATING THE UPTAKE INTO CELLS
#4123Compositions and Methods to Monitor RNA Delivery to Cells
#4124Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secodary rna structure
#4125ENCAPSULATED NANOPARTICLES FOR DRUG DELIVERY
#4126Protection against and treatment of age related macular degeneration
#4127Cancer therapy using Bcl-X-specific siNA
#4128Screening method
#4129Materials and methods directed to asparagine synthetase and asparaginase therapies
#4130RIBOZYME MEDIATED STABILIZATION OF POLYNUCLEOTIDES
#4131siRNA targeting TNFα
#4132CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION
#4133Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification
#4134Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors
#4135Immuno-RNA-constructs
#4136Treating severe and acute viral infections
#4137Treatment of metastatic tumors
#4138SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
#4139Regulation of epigenetic control of gene expression
#4140Multiple RNA polymerase III promoter expression constructs
#4141siRNA targeting KRAS
#4142Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#4143METHOD FOR INTRODUCING SIRNA INTO CELLS BY PHOTOCHEMICAL INTERNALISATION
#4144Cell penetrating peptides for intracellular delivery of molecules
#4145Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#4146Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#4147siRNA targeting transducin (beta)-like 3 (TBL3)
#4148Ligand-conjugated monomers
#4149Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
#4150Compositions and methods for delivering RNAI using lipoproteins
#4151NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF MICRORNAS AND THEIR TARGET MRNAS
#4152METHODS AND COMPOSITIONS FOR USE IN PREPARRING siRNAs
#4153Random RNAi libraries, methods of generating same, and screening methods utilizing same
#4154Oligonucleotides comprising a non-phosphate backbone linkage
#4155siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
#4156STABILIZED SIRNAS AS TRANSFECTION CONTROLS AND SILENCING REAGENTS
#4157ENHANCEMENT OF DRUG THERAPY BY MIRNA
#4158FERRITIN AS A THERAPEUTIC TARGET IN ABNORMAL CELLS
#4159Delivery Of Double-Stranded RNA Into The Central Nervous System
#4160siRNA targeting inner centromere protein antigens (INCENP)
#4161Method of inhibiting human Trabid
#4162Modified siRNA molecules and uses thereof
#4163Means and method for inducing exon-skipping
#4164Conjugates and compositions for cellular delivery
#4165Double helical oligonucleotides interfering with mRNA used as effective anticancer agents
#4166Focused libraries, functional profiling, laser SELEX, and DESELEX
#4167RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#4168MIRNAS DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
#4169Method and constructs for delivering double stranded RNA to pest organisms
#4170Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
#4171DOUBLE STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME
#4172GENE KNOCK-DOWN BY INTRACELLULAR EXPRESSION OF APTAMERS
#4173Cellular Delivery of siRNA
#4174pCryptoRNAi
#4175siRNA targeting gremlin
#4176Triggered RNAi
#4177RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#4178dsRNA compositions and methods for treating HPV infection
#4179RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#4180Small interfering RNAS as non-specific drugs
#4181Multitargeting Interfering RNAs And Methods Of Their Use And Design
#4182METHOD OF DELIVERY OF NUCLEIC ACIDS TO A DEVELOPING EMBRYO
#4183Signal activated RNA interference
#4184Compounds for Hydrolyzing Ribonucleic Acids (RNA's)
#4185Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery systems
#4186METHOD OF PRODUCING IMMUNOLIPOSOMES AND COMPOSITIONS THEREOF
#4187siRNA targeting connexin 43
#4188Process for the Preparation of Nucleic Acid Duplexes
#4189Oligomeric compounds and compositions for the use in modulation of microRNAs
#4190Novel HIV Targets
#4191Amphoteric liposome formulation
#4192Method of cancer treatment using siRNA silencing
#4193Biotinylated compositions
#4194Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of TINA
#4195Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
#4196COMPOSITIONS AND METHODS FOR REGULATING GENE TRANSCRIPTION
#4197RNA interference induction element and use thereof
#4198Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
#4199SHRNA AND SIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE
#4200Oligonucleotides with alternating segments of locked and non-locked nucleotides